Page last updated: 2024-08-23

phenyl acetate and chronic COVID syndrome

phenyl acetate has been researched along with chronic COVID syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Almeda-Ortega, J; Alvarez-Muñoz, G; Balanzo-Joué, M; Bonet-Monne, S; Contreras-Martos, S; Cunillera-Puèrtolas, O; García-Sangenís, A; Mera-Cordero, F; Monfà, R; Morros, R; Salvador-Gonzalez, B	1

Trials

1 trial(s) available for phenyl acetate and chronic COVID syndrome

Article	Year
Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol. Trials, 2022, Jan-06, Volume: 23, Issue:1 Topics: Acetates; COVID-19; Cyclopropanes; Double-Blind Method; Humans; Oxygen Saturation; Post-Acute COVID-19 Syndrome; Quality of Life; Quinolines; Randomized Controlled Trials as Topic; SARS-CoV-2; Sulfides; Treatment Outcome	2022

Article

Year

Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol.

Trials, 2022, Jan-06, Volume: 23, Issue:1

Topics: Acetates; COVID-19; Cyclopropanes; Double-Blind Method; Humans; Oxygen Saturation; Post-Acute COVID-19 Syndrome; Quality of Life; Quinolines; Randomized Controlled Trials as Topic; SARS-CoV-2; Sulfides; Treatment Outcome

2022